Cell Therapy Field Clinical Advisor

Scientific Expertise and Education

• Pipeline Mastery at Scale: Build and continuouslymaintaindeep knowledge of AstraZenecas cell therapy pipeline across multiple indications andassets.

• Recognized Thought Leadership:Establishand sustain highest-level scientific and medicalexpertisein celltherapy; recognizedinternally and externally as a go-to expert shaping guidancetraining and best practices for assigned protocols and sites

• Strategic Portfolio Communication: Lead site-facing and expert stakeholder communications that clearly convey AstraZenecas cell therapy strategy portfolio breadth and product differentiation; ensure consistent compliant messaging across regions.

• Initiative Ownership and Execution: Design lead and implement high-impact local initiatives with trialists and key experts to support R&D or study implementation aligned with GPT Global R&D and Country Medical Affairs; track outcomes and scale successful approaches.

• Education Gap Identification and Closure: Systematically assess educational needs across owned sites deliver advancedprotocoltraining and escalate patterns to Global Clinical Development with recommendations for enterprise-level solutions.

• Insight Generation and Influence: Capture synthesize and deliver actionable field insights (feasibility operational bottlenecks patient pathways) to global and local stakeholders; drive early risk identification and influence protocol/process adjustments.

Clinical Trial Support

• Advanced Education and Readiness: Lead delivery of SIV content; provide advanced protocol education and competency-based staff training to ensure readiness compliance and consistency across sites and indications.Drive patient selection quality safety management and site-specific action plans;deliver measurable improvements in start-up timelines and protocol adherence

• Recruitment and Retention Performance: Implement targetedprotocoleducation(e.g. inclusion/exclusion criteria applicationetc.)toupliftenrolmentrates reduce screen failures and minimize attrition.

• Issue Triage Escalation and Risk Mitigation: Serve as the primary field point forprotocol andclinical issues; triage and escalate appropriately drive root-cause analysis and implement corrective/preventive actions to reduce deviations and data queries.

• Structured Compliant Scientific Exchange: Leadtimely high-quality scientific and medical communications with trialists and internal partners ensuring alignment with compliance policies and legal requirements; standardize messaging and capture learnings for reuse.

• Insight Loop and Continuous Improvement: Systematically capture site-level insights; synthesize trends for study teams and cross-functional stakeholders influencing protocol/process adjustments and scaling proven practices.

Operational

• Cross-functional orchestration: Lead coordinated delivery withCTCO FunctionsClinical Development Medical Affairs Supply/LogisticsPatient OperationsandCountry Opsto ensure rapid reliable service to internal stakeholders and study sites.

• Portfolio coverage and resiliency: Provide proactive coverage for other FCAs and high-priority sites; implement standardized playbooks tomaintaincontinuity of operations during surges vacations or escalations.

• Regulatory and policy stewardship:Maintaincurrent knowledge of local regulations guidelines codes of practice and AstraZeneca policies relevant to Clinical Development; translate requirements into practical site actions and support inspection readiness.

• External scientific engagement: Attend and contribute at relevant scientific meetings and conferences; synthesize takeaways into concise briefs and recommendations for study teams and operational processes.

• Innovation sourcing and scaling: Build relationships with industry leaders and ecosystem partners;identify pilot and scale innovations (e.g. workflow toolslogisticsoptimizations patient support solutions) that improve cycle times quality and site experience.

Cross Functional

• Globalworkstreams: Providecountry specificfield insights and subject-matterexpertiseto priority global initiatives; review/shape core strategies and deliverables to enable scalable locally compliant adoption.

• Medical Affairs: Partner on scientific strategy congress/education plans and field content; ensure accuracy balance andgovernancecompliance across materials and training.

• Commercial (within governance): Coordinate through approved interfaces to align on market dynamicsandobjectives

• Evidence and insights: Elevate actionable field signals to inform globalresearchstrategy and lifecycle plans; ensure traceability from signal to decision.

• Governance:Operatewithin AZ policies/SOPs and local regulations

Impact

• Operational velocity and quality: Directly improve speed quality and consistency of AstraZenecas cell therapy trialsreducing cycle times elevating protocol adherence and accelerating patient access to innovative treatments.

Education QualificationsSkillsand Experience

Essential

• Education: Bachelors degree in a health-related field; advanced degree (PharmD PhD MSc NP/PA MD/RN) preferred.